Theseus Pharmaceuticals Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Theseus Pharmaceuticals is a Cambridge, Massachusetts-based biotechnology research company focused on developing targeted cancer therapies. The organization emphasizes advancing treatments that anticipate cancer’s mutations, aiming to overcome resistance to initial oncology therapies by pursuing best-in-class, pan-variant inhibitors for kinase targets. Its work centers on discovering and developing therapies that stay ahead of tumor evolution, addressing the persistent burden of treatment resistance in cancer care. The company operates within the biotechnology research sector, with a small-to-mid sized team and a stated emphasis on pioneering approaches to tyrosine kinase inhibitors and related targeted therapies. Its activities include early-stage development and strategic program exploration, such as initiatives targeting KIT in gastrointestinal stromal tumors. Recent organizational changes and industry developments have involved leadership appointments and corporate transactions, reflecting a dynamic environment in which Theseus operates.